Gaithersburg's Novavax awarded $1.6B to further develop its coronavirus vaccine
Gaithersburg, Maryland-based Novavax, a clinical-stage biotech company that develops vaccines to prevent serious infectious diseases, has been awarded $1.6 billion to participate i…
